Genmab A/S (GMAB)
38.48
+3.73
(+10.73%)
USD |
NASDAQ |
Oct 05, 16:00
38.41
-0.07
(-0.18%)
After-Hours: 04:57
Genmab Profit Margin (Quarterly) : 26.23% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.23% |
| March 31, 2026 | 5.92% |
| December 31, 2025 | 2.93% |
| September 30, 2025 | 39.24% |
| June 30, 2025 | 36.32% |
| March 31, 2025 | 27.27% |
| December 31, 2024 | 59.70% |
| September 30, 2024 | 22.85% |
| June 30, 2024 | 26.06% |
| March 31, 2024 | 31.98% |
| December 31, 2023 | 13.68% |
| September 30, 2023 | 44.65% |
| June 30, 2023 | 32.02% |
| March 31, 2023 | 7.41% |
| December 31, 2022 | 11.17% |
| September 30, 2022 | 63.18% |
| June 30, 2022 | 59.80% |
| March 31, 2022 | 21.94% |
| December 31, 2021 | 27.34% |
| September 30, 2021 | 38.53% |
| June 30, 2021 | 15.52% |
| March 31, 2021 | 69.32% |
| December 31, 2020 | 28.42% |
| September 30, 2020 | 30.74% |
| June 30, 2020 | 61.97% |
| Date | Value |
|---|---|
| March 31, 2020 | 30.16% |
| December 31, 2019 | 49.70% |
| September 30, 2019 | 51.65% |
| June 30, 2019 | 10.97% |
| March 31, 2019 | 12.22% |
| December 31, 2018 | 67.47% |
| September 30, 2018 | 29.93% |
| June 30, 2018 | 51.12% |
| March 31, 2018 | 29.16% |
| December 31, 2017 | 77.21% |
| September 30, 2017 | -1.76% |
| June 30, 2017 | 39.73% |
| March 31, 2017 | 6.42% |
| December 31, 2016 | 90.72% |
| September 30, 2016 | 51.82% |
| June 30, 2016 | 47.55% |
| March 31, 2016 | -6.77% |
| December 31, 2015 | 67.77% |
| September 30, 2015 | 50.50% |
| June 30, 2015 | 9.49% |
| March 31, 2015 | |
| December 31, 2014 | 31.98% |
| September 30, 2014 | 58.90% |
| June 30, 2014 | -22.55% |
| March 31, 2014 | 39.87% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ascendis Pharma A/S | 61.00% |
| Zealand Pharma A/S | 87.22% |
| AbbVie, Inc. | 21.21% |
| Bavarian Nordic A/S | 36.03% |
| Evaxion AS | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.77% |
| Return on Assets | 7.67% |
| Return on Invested Capital | 8.76% |
| Gross Profit Margin (Quarterly) | 92.73% |
| Operating Margin (Quarterly) | 35.24% |
| Return on Net Operating Assets | 10.40% |